Phylogica signs peptide vaccines deal with Pfizer
20 December, 2010 by David BinningPerth drug developer Phylogica has signed a licensing and collaboration agreement with Pfizer which will see the two companies work together to develop novel peptide-based vaccines.
Feature: Manufacturing monoclonal antibodies
20 December, 2010 by Fiona WylieThe journey to market for biological products can be a complex and frustrating process. A key challenge in this process is producing or obtaining the relevant compounds in quantities large enough to support research studies, pre-clinical studies and/or early-stage clinical trials.
China healthcare reforms up the stakes for big pharma: Datamonitor
17 December, 2010 by Staff WritersIt’s a market once deemed ‘too-hard’ by biotech and pharma companies, but with the Chinese government set to spend $US125 billion on healthcare by the end of next year, it’s an opportunity too hot to ignore.
HealthLinx reports solid data from OvPlex study
15 December, 2010 by Staff WritersAustralian diagnostic specialists HealthLinx reported today that the initial data from a second multinational study involving its ovarian cancer diagnostic OvPlex demonstrate a marked increase in diagnostic effectiveness compared to relying only on the standard CA125 blood test.
Market report: Biotech stocks rise for yet another week
10 December, 2010 by David BinningThe S&P/ASX 200 Heathcare Index continued its march towards 9000 points this week as the broader market eked out a small gain for the second week in a row.
Market report: Biotechs up for fourth week in a row
03 December, 2010 by David BinningThe S&P/ASX 200 Heathcare Index close in the black for the fourth week in a row today, partly buoyed by a strong come back from the wider market, which snapped its losing streak.
vivoPharm opening for business in the U.S
26 November, 2010 by Staff WritersAdelaide-based contract research organisation vivoPharm has received $US1.3 million to help fund building of the company’s first facility in the U.S.
Australian researchers claim cure for high blood pressure
19 November, 2010 by David BinningResearchers at the Baker IDI Heart and Diabetes Institute in Melbourne have released the results of an international patient trial of a novel new treatment based on radio waves which they say has the potential to revolutionise treatment for blood pressure and other conditions.
Feature: Designing drought tolerant crops
15 November, 2010 by Graeme O'NeillIn the past decade, the zero-till revolution has rolled across wheat farms on the margins of the arid zone in south-eastern Australia, helping wheat growers survive the longest and deepest drought since European settlement.
Anti-GM activists hijack Economist debate on biotechnology and agriculture
13 November, 2010 by Tim DeanBritish news and analysis magazine, The Economist, has announced the results of its recent debate on biotechnology and sustainable agriculture finding a majority of voters in opposition of the motion, yet suggesting that technical difficulties and a coordinated effort by anti-GM activists has skewed the result.
HealthLinx reports strong results from ovarian cancer study
12 November, 2010 by Staff WritersShares in diagnostics company HealthLinx surged 18 percent today after the company announced positive results from its independent, multi-centre, multi-site second study for OvPlex based on two new biomarkers being evaluated as diagnostics for ovarian cancer.
Patrys reports positive early stage data from melanoma clinical trial
10 November, 2010 by Staff WritersShares in Melbourne biotech Patrys jumped by 15 per cent by late morning today after the company announced that it has completed treatment of the first patient group in the melanoma trial of its natural human antibody product PAT-SM6.
LCT moves closer to Parkinson’s cure
10 November, 2010 by David BinningLiving Cell Technologies reported today that its NTCELL cell implant product for neurodegenerative conditions has demonstrated effectiveness in two pre-clinical models of Parkinson's disease.
Beta blockers shown to combat osteoporosis
09 November, 2010 by Staff WritersResearchers from Sydney’s Garvan Institute of Medical Research have shown that beta blockers can increase bone density and reduce the risk of osteoporotic fracture in around 50 per cent of patients.
Feature: Algal biofuels and the future of renewable energy
05 November, 2010 by Fiona WylieA group of specially adapted green algae may hold the answer to sustainable and renewable energy for the future, helped by the Sun and more than a pinch of clever science.
